bioMérieux Showcases State-Of-The-Art Data and Connectivity Tools

bioMérieux (Marcy l'Etoile, France) is showcasing its latest innovations at Medlab Middle East 2025 that are designed to support the timely delivery of results for impacting patient therapy.

Stopping the spread of resistant organisms means ensuring patients get the right dose at the right time. bioMérieux offers a one-stop-shop to provide critical diagnostic results the length of the antimicrobial resistance (AMR) patient pathway from therapy initiation to optimization to discontinuation. At the 2025 edition of Medlab Middle East, bioMérieux is exhibiting the VITEK® MS PRIME new-generation mass spectrometry microbial identification system. VITEK® MS PRIME combines microbiology expertise with innovation, taking mass spectrometry to the next level by maximizing the impact of daily laboratory workflow for better patient care. Alongside, bioMérieux is presenting the newest addition to its Sepsis Solution, VITEK® REVEAL™ which offers rapid antimicrobial susceptibility testing (AST) results to effectively and efficiently manage bloodstream infections

bioMérieux is also showcasing its stackable benchtop automated immunoassay solution, VIDAS® KUBE™ that is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence. VIDAS® KUBE™ adaptable automation helps labs be more productive, more accurate, and more innovative – all in one simplified platform. Scaling with ease, VIDAS® KUBE™ is a simple and reliable addition to evolving labs, offering smart innovations that are both time- and cost-saving.

bioMérieux is contributing to the fight against AMR by expanding syndromic testing technology outside traditional clinical laboratories to the point-of-care settings to provide patients with fast answers, while giving clinicians the information they need to make timely, targeted treatment decisions. Among its solutions are BIOFIRE® FIREWORKS™ and BIOFIRE® SPOTFIRE® Respiratory Panels for providing access to a centralized data management web portal to give users total insights and analytics into BIOFIRE® System performance, utilization, pathogen surveillance, workflow management, and more. Also featuring at the event is the BIOFIRE® SPOTFIRE® System, the latest advancement in molecular infectious disease diagnostics from bioMérieux, with all of its expertise and cutting-edge FILMARRAY® technology at the heart of the system design.